Alexei Hernandez

593 total citations
12 papers, 78 citations indexed

About

Alexei Hernandez is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Alexei Hernandez has authored 12 papers receiving a total of 78 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Oncology. Recurrent topics in Alexei Hernandez's work include Single-cell and spatial transcriptomics (5 papers), Immune cells in cancer (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Alexei Hernandez is often cited by papers focused on Single-cell and spatial transcriptomics (5 papers), Immune cells in cancer (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Alexei Hernandez collaborates with scholars based in United States and France. Alexei Hernandez's co-authors include Won Jin Ho, Sarah M. Shin, Elizabeth M. Jaffee, Nicole Groß, Soren Charmsaz, Daniel Shu, Erin M. Coyne, Stephanie Xavier, A.I. Saeed and Luciane T. Kagohara and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Cancer Research.

In The Last Decade

Alexei Hernandez

9 papers receiving 78 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexei Hernandez United States 5 40 30 25 18 12 12 78
Sarah M. Shin United States 4 36 0.9× 28 0.9× 24 1.0× 17 0.9× 11 0.9× 11 73
Jinxia Bao China 4 37 0.9× 25 0.8× 21 0.8× 17 0.9× 10 0.8× 5 71
Divya Sakamuri United States 5 45 1.1× 22 0.7× 21 0.8× 9 0.5× 14 1.2× 6 75
Qichao Yu China 7 29 0.7× 71 2.4× 27 1.1× 30 1.7× 11 0.9× 9 110
Aarti Kolluri United States 3 28 0.7× 53 1.8× 21 0.8× 15 0.8× 7 0.6× 5 97
Mengxue Pan China 5 35 0.9× 42 1.4× 10 0.4× 17 0.9× 14 1.2× 6 96
Stephanie Xavier United States 4 45 1.1× 30 1.0× 29 1.2× 18 1.0× 19 1.6× 5 111
Xinjun Liang China 5 36 0.9× 39 1.3× 32 1.3× 18 1.0× 21 1.8× 11 96
Hongyu Shi China 5 19 0.5× 43 1.4× 14 0.6× 14 0.8× 8 0.7× 11 71
Zhaohui Wei China 5 23 0.6× 47 1.6× 35 1.4× 19 1.1× 8 0.7× 7 110

Countries citing papers authored by Alexei Hernandez

Since Specialization
Citations

This map shows the geographic impact of Alexei Hernandez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexei Hernandez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexei Hernandez more than expected).

Fields of papers citing papers by Alexei Hernandez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexei Hernandez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexei Hernandez. The network helps show where Alexei Hernandez may publish in the future.

Co-authorship network of co-authors of Alexei Hernandez

This figure shows the co-authorship network connecting the top 25 collaborators of Alexei Hernandez. A scholar is included among the top collaborators of Alexei Hernandez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexei Hernandez. Alexei Hernandez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Christenson, Eric S., Tri‐Long Nguyen, Soren Charmsaz, et al.. (2025). Ablating UNG activity in a mouse model inhibits colorectal cancer growth by increasing tumor immunogenicity. JCI Insight. 10(16).
3.
Durham, Jennifer N., Leslie Cope, Soren Charmsaz, et al.. (2025). Entinostat in combination with nivolumab for patients with advanced cholangiocarcinoma: a phase 2 clinical trial. SHILAP Revista de lepidopterología. 5(1).
4.
Patel, Jay, Junwen Deng, Anusha Kambala, et al.. (2024). Spatial Mass Cytometry–Based Single-Cell Imaging Reveals a Disrupted Epithelial–Immune Axis in Prurigo Nodularis. Journal of Investigative Dermatology. 144(11). 2501–2512.e4. 3 indexed citations
5.
Grasset, Eloïse M., Atul Deshpande, Jae W. Lee, et al.. (2024). Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells. Oncogene. 43(39). 2927–2937. 2 indexed citations
6.
Charmsaz, Soren, Nicole Groß, Jae W. Lee, et al.. (2024). Abstract 5306: PTPN22 targeting partners with 41BB/OX40 costimulation to overcome anti-PD1 resistance in pancreatic ductal adenocarcinoma. Cancer Research. 84(6_Supplement). 5306–5306. 1 indexed citations
7.
Charmsaz, Soren, Nicole Groß, Alexei Hernandez, et al.. (2024). Abstract B003: Validating PTPN22 as a cancer-agnostic immunotherapeutic target. Cancer Immunology Research. 12(10_Supplement). B003–B003. 2 indexed citations
8.
Li, Yan, Meredith L. Stone, Devora Delman, et al.. (2024). Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer. Cell Reports Medicine. 5(2). 101397–101397. 17 indexed citations
9.
Huff, Amanda L., Emily F. Davis-Marcisak, Thatcher Heumann, et al.. (2023). Abstract LB197: A pooled mutant KRAS peptide vaccine activates polyfunctional T cell responses in patients with resected pancreatic cancer. Cancer Research. 83(8_Supplement). LB197–LB197. 5 indexed citations
10.
Shin, Sarah M., Alexei Hernandez, Erin M. Coyne, et al.. (2023). Abstract 2270: Combination of CXCR4 antagonist and anti-PD1 therapy results in significant mobilization and increased infiltration of myeloid cells into the metastatic liver microenvironment of PDAC. Cancer Research. 83(7_Supplement). 2270–2270. 6 indexed citations
11.
Shin, Sarah M., Alexei Hernandez, Erin M. Coyne, et al.. (2022). CyTOF protocol for immune monitoring of solid tumors from mouse models. STAR Protocols. 4(1). 101949–101949. 4 indexed citations
12.
Zabransky, Daniel J., Ludmila Danilova, James M. Leatherman, et al.. (2022). Profiling of syngeneic mouse HCC tumor models as a framework to understand anti–PD‐1 sensitive tumor microenvironments. Hepatology. 77(5). 1566–1579. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026